UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
January 3, 2020
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Tesla, Inc.
File No. 1-34756 - CF#35364
_____________________
Tesla, Inc. submitted an application under Rule 24b-2 requesting an extension of a previous grant of confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on August 4, 2017.
Based on representations by Tesla, Inc. that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibits will not be released to the public for the time period specified:
Exhibit 10.4 | through December 31, 2020 |
Exhibit 10.5 | through December 31, 2020 |
Exhibit 10.7 | through December 31, 2020 |
Exhibit 10.8 | through December 31, 2020 |
For the Commission, by the Division of Corporation Finance, pursuant to delegated authority:
Vanessa A. Countryman
Secretary
Attachments
- Original document
- Permalink
Disclaimer
Tesla Inc. published this content on 03 January 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 January 2020 14:12:05 UTC